Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients

Atherosclerosis

Volumn 152, Issue 2, 2000, Pages 511-518

  Perticone, Francesco ^a   Ceravolo, Roberto ^a   Maio, Raffaele ^a   Cloro, Cosima ^a   Candigliota, Mafalda ^a   Scozzafava, Angela ^a   Mongiardo, Annalisa ^a   Mastroroberto, Pasquale ^a   Chello, Massimo ^a   Mattioli, Pier L ^a  

^a Dept Med Sperim Clin 'G S ^*  (Italy)

Author keywords

Atherosclerosis; Atorvastatin; Endothelium; Hypercholesterolemia; Vitamin C

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; ATORVASTATIN; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM; PLACEBO;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ADULT; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD FLOW VELOCITY; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; PYRROLES; VASODILATION; VASODILATOR AGENTS;

EID: 0033817532     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00370-1     Document Type: Article

References (41)

1. Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323:1990;27-36.
2. Furchgott R.F., Zawadzki J.V. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
3. Palmer R.M.J., Ferridge A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
4. Lüsher T.F., Vanhoutte P.M. The Endothelium: Modulator of Cardiovascular Function. 1990;CRC Press, Boca Raton, FL.
5. Vanhoutte P.M., Rubanyi G.M., Miller V.M., Houston D.S. Modulation of vascular smooth muscle contraction by the endothelium. Ann. Rev. Physiol. 48:1986;307-320.
6. Smith R.P., Kruszyna H. Nitroprusside produces cyanide poisoning via reaction with hemoglobin. J. Pharmacol. Exp. Ther. 191:1974;557-563.
7. Lüsher T.F., Cooke J.P., Houston D.S., Neves R.J., Vanhoutte P.M. Endothelium-dependent relaxations in human arteries. Mayo. Clin. Proc. 62:1987;601-606.
8. Thom S., Hughes A., Martin G., Sever P.S. Endothelium-dependent relaxation in isolated human arteries and veins. Clin. Sci. 73:1987;547-552.
9. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 2:1989;997-1000.
10. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323:1990;22-27.
11. Linder L., Kiowski W., Bühler F.R., Lüsher T.F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 81:1990;1762-1767.
12. Zeither A.M., Drexler H., Saubier B., Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolaemia and hypertension. J. Clin. Invest. 92:1993;652-662.
13. Zeiher A.M., Schachinger V., Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilation function. Circulation. 92:1995;1094-1100.
14. Johnstone M.T., Creager S.J., Scales K.M., et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
15. Creager M.A., Cooke J.P., Mendelson M.E., et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86:1990;228-234.
16. Ting H.H., Timini F.K., Haley E.A., et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:1997;2617-2622.
17. Anderson T.J., Meredith I.T., Yeung A.C. The effect of cholesterol-lowering and anti-oxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332:1995;488-493.
18. McCrohon J.A., Adams M.R., McCredie R.J., et al. Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin. Endocrinol. 45:1996;435-441.
19. Stroes E.S.G., Koomans H.A., de Bruin T.W.A., Rabelink T.J. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication. Lancet. 346:1995;467-471.
20. O'Driscoll G., Green D., Taylor R.R. Simvastatin, an HMG-Coenzyme A reductase inhibitor, improve endothelial function in 1 month. Circulation. 95:1997;1126-1131.
21. Mancini G.B.J., Hanry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 94:1996;258-265.
22. Taddei S., Virdis A., Ghiadoni L., et al. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension. 30:1997;1606-1612.
23. Perticone F., Ceravolo R., Mario R., et al. Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients. Cardiovasc. Res. 41:1999;299-306.
24. Scandinavian Simvastatin Survival Study: Investigators Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
25. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study. N. Engl. J. Med. 333:1995;1301-1307.
26. Alanpovic P., Heinonen T., Shurzinske L., Black D.M. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels. Atherosclerosis. 133:1997;123-133.
27. Simons L.A., Sullivan D., Simons J., Celermajer D.S. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolemia. Atherosclerosis. 137:1998;197-203.
28. Perticone F., Ceravolo R., Maio R., et al. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension. 31:1998;900-905.
29. Heitzer T., Just H., Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 94:1996;6-9.
30. Taddei S., Virdis A., Ghiadoni L., Magagna A., Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 97:1998;2222-2229.
31. Timini F.K., Ting H.H., Haley E.A., et al. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 31:1998;552-557.
32. Gauthier T.W., Scalia R., Murohara T., Guo J.P., Lefer A.M. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscl. Thromb. Vasc. Biol. 15:1995;1652-1659.
33. de Graaf J.C., Banga J.D., Moncada S., et al. Nitric oxide inhibitor of platelet adhesion under flow conditions. Circulation. 85:1992;2284-2290.
34. Draijier R., Atsma D.E., van der Laarse A., van Hinsbergh V.W. cGMP and nitric oxide modulate thrombin-induced endothelial permeability: regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ. Res. 76:1995;199-208.
35. Sarkar R., Webb R.C., Stanley J.C. Nitric oxide inhibition of endothelial mitogenesis and proliferation. Surgery. 118:1995;274-279.
36. Andrews H.E., Bruckdorfer K.R., Dunn R.C., Jacobs M. Low density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 327:1987;237-239.
37. Murphy M.E., Piper H.M., Watanabe H., Sies H. Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J. Biol. Chem. 266:1991;19378-19383.
38. Gellmann J., Ezekowitz M.D., Sarembock I.J., et al. Effect of lovastatin on intima hyperplasia after balloon angioplasty. A study in an atherosclerotic hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 17:1991;251-259.
39. Giroux L.M., Davignon J., Naruszewicz M. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human mocyte-derived macrophages. Biochim. Biophys. Acta. 1165:1993;335-338.
40. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S. Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis. 138:1998;271-280.
41. Harrison D.G., Armstrong M.L., Freiman P.C., Heistad D.D. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J. Clin. Invest. 80:1987;1808-1811.